CJC+IPA Research Peptide
Price range: $70.00 through $140.00
CJC+IPA is a defined research peptide blend containing CJC-1295 no DAC and Ipamorelin. It is supplied in lyophilized powder form for qualified laboratory and analytical research.
The product is intended for controlled research workflows involving compound identification, analytical characterization, sample documentation, inventory management, and comparative peptide research. Product information is limited to the material’s documented composition and laboratory classification.
CJC+IPA specifications
- Product Name: CJC+IPA
- Active Compounds: CJC-1295 no DAC and Ipamorelin
- Form: Lyophilized powder
- Classification: Research peptide blend
- Research Application: Laboratory and analytical research
- Product Format: Defined peptide combination
The stated specifications can be used for laboratory records, inventory documentation, sample identification, and research material tracking.
What is CJC+IPA?
CJC+IPA is a defined combination of two research compounds: CJC-1295 no DAC and Ipamorelin.
The combination is supplied as a single research material, allowing qualified laboratories to document the product as part of controlled experimental workflows. Researchers can evaluate the material according to their own validated methods, analytical requirements, and institutional procedures.
CJC+IPA is supplied strictly as a research material. No human-use application, administration procedure, or dosing information is provided.
What is CJC-1295 no DAC?
CJC-1295 no DAC is the CJC-1295 form identified as one component of the CJC+IPA research material. The “no DAC” designation distinguishes this material from CJC-1295 forms identified with the Drug Affinity Complex.
For research purposes, CJC-1295 no DAC can be documented by its compound identity, batch information, analytical characteristics, and applicable product documentation.
The compound may also appear in research-related searches under terms such as CJC 1295 no DAC, CJC 1295 peptide no DAC, and CJC 1295 no DAC research chemical.
What is Ipamorelin?
Ipamorelin is the second identified compound in the CJC+IPA research material.
Within a laboratory environment, researchers may document Ipamorelin according to its compound identity, batch information, analytical characteristics, and applicable research documentation.
Any experimental evaluation should be conducted under the qualified research organization’s established protocols and applicable laboratory requirements.
Areas of laboratory research
CJC+IPA may be relevant to controlled laboratory work involving:
- Peptide identification
- Analytical characterization
- Comparative peptide analysis
- Compound composition studies
- Sample tracking
- Research inventory management
- Laboratory method development
- Peptide structure research
- Material stability evaluation
- Analytical method validation
These categories describe potential laboratory research activities only. They are not claims regarding human effects, therapeutic properties, performance, or consumer applications.
CJC+IPA analytical research
Researchers may evaluate CJC+IPA using analytical procedures appropriate to their research objectives.
Depending on the laboratory’s requirements, research workflows may involve documenting compound identity, evaluating material characteristics, comparing samples, or maintaining batch-specific records.
Laboratories should establish their own validated analytical methods, specifications, and acceptance criteria for experimental work.
CJC+IPA COA and documentation
A batch-specific Certificate of Analysis (COA) can be maintained as part of laboratory documentation.
Depending on the documentation provided with a specific batch, researchers may review information such as:
- Product identification
- Batch or lot number
- Stated purity
- Analytical test results
- Product quantity
- Manufacturing information
- Storage information
Researchers requiring additional verification should conduct appropriate independent analytical testing according to their established laboratory procedures.
CJC+IPA procurement
Researchers evaluating CJC+IPA should review the product identity, stated composition, available analytical documentation, batch information, packaging, storage requirements, and research-use classification before procurement.
For researchers searching to buy CJC 1295 no DAC, product documentation should be reviewed carefully to confirm that the material corresponds with the intended research requirements.
Price should be considered alongside product documentation, material specifications, batch information, and analytical records.
Product care and storage
CJC+IPA is supplied as a lyophilized powder.
Store the unopened material according to the storage conditions specified in the applicable product documentation and Certificate of Analysis. Protect the material from unnecessary exposure to heat, moisture, and direct light.
Researchers should follow their own laboratory SOPs for material handling, storage, analytical preparation, and disposal.
Lumex Labs does not provide dosing, administration, injection, needle-related, or human-use instructions for this research material.
Product information
| Specification | Details |
| Product Name | CJC+IPA |
| Active Compounds | CJC-1295 no DAC + Ipamorelin |
| Form | Lyophilized Powder |
| Category | Research Peptides |
| Classification | Research Peptide Blend |
| Application | Laboratory and Analytical Research |
Research use only
CJC+IPA is supplied exclusively for scientific, analytical, and laboratory research.
It is not intended for human or veterinary consumption or administration. No dosing, injection, administration, or human-use instructions are provided.
Researchers are responsible for following applicable institutional requirements, laboratory SOPs, safety procedures, and relevant regulations when handling, analyzing, storing, and disposing of research materials.
Frequently asked questions
What is CJC+IPA?
CJC+IPA is a defined research peptide blend containing CJC-1295 no DAC and Ipamorelin in lyophilized powder form.
What compounds are included in CJC+IPA?
The product is identified as containing CJC-1295 no DAC and Ipamorelin.
What is CJC-1295 no DAC?
CJC-1295 no DAC is the specific CJC-1295 form identified in this research material. The “no DAC” designation distinguishes it from forms described with the Drug Affinity Complex.
What is CJC+IPA intended for?
CJC+IPA is supplied for qualified laboratory and analytical research, including compound identification, characterization, comparative analysis, sample documentation, and related research workflows.
What documentation should researchers review?
Researchers should review the product specifications and applicable batch-specific documentation, including the available Certificate of Analysis and stated analytical information.
Does Lumex Labs provide dosing or administration instructions?
No. Lumex Labs does not provide dosing, injection, needle-related, administration, or human-use instructions for CJC+IPA.
How should CJC+IPA be stored?
The unopened lyophilized material should be stored according to the applicable product documentation and COA. Researchers should follow their established laboratory SOPs for handling and storage.
The LumexLabs Standard
Third-party tested
Every batch is identity-verified by an independent U.S. laboratory using HPLC and mass spectrometry before it goes on sale.
CoA with every lot
Batch-specific Certificates of Analysis documenting purity and molecular identity, available within 24 hours on request.
Fast, discreet shipping
Orders placed before 2 PM EST ship the same business day in plain, unbranded packaging with full tracking.
U.S. sourced & finished
Raw materials sourced and finished in the United States with full chain-of-custody records from raw material to vial.
* All products are sold strictly for laboratory and in-vitro research use only. They are not for human or veterinary use of any kind. The information on this page is a summary and is not a substitute for the expertise and judgement of a qualified professional.